SignaGen LV-CAG-GCaMP6s premade lentiviral vector map
LV-CAG-GCaMP6s

Price range: $236.00 through $468.00

In stock

Add to cart This product has multiple variants. The options may be chosen on the product page

LV-CAG-GCaMP6s

SKU: SL100334 Category:
  • Experimentally Validated
  • Reproducible Performance
  • Dedicated Scientific Support
  • Customization Options Available

Bulk Inquiry

Customize promoter, reporter, or antibiotic selection

Product Category: Pre-made recombinant lentivirus; LV-CAG-GCaMP6s; CAG-GCaMP6s Lentivirus

Description: GCaMP is a genetically encoded calcium indicator (GECI) and was created from a fusion of green fluorescent protein (GFP), calmodulin (CaM), and M13, a peptide sequence from myosin light chain kinase. When GECI binds Ca2+, the conformational change of GCaMP induces proximity of the GFP parts, eliciting a strong GFP fluorescence signal, which allows measuring action potentials and other receptor activation events that trigger Ca2+ influx. The advantage of GECI is that they can be genetically specified for studies in living organisms.

GCaMP6 is a novel ultra-sensitive format of GCaMP that outperformed other sensors in terms of accuracy and sensitivity in measuring cytosol Ca2+ level. Mutations in calmodulin part of GCaMP6 created several variants which showed different calcium fluorescence decay rate (fast – GCaMP6s, slow – GCaMP6s, and medium – GCaMP6m).

LV-CAG-GCaMP6s is a pre-made lentivirus that expresses GCaMP6s under the CAG promoter. Ready to use format.

Titer: >1E+9 TU/mL

Selection Antibiotic: None

Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection

Size: 2 x 25 µL (Std Pack)

Storage Buffer: PBS

Infection Protocol:

Transfer Vector Map:
SignaGen LV-CAG-GCaMP6s premade lentiviral vector construct map showing CAG promoter, GCaMP6s calcium indicator and lentiviral LTR elements

* Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm

CITATIONS

Human in vitro neuromuscular junction model to functionally dissect the pathogenic mechanism of anti-AChR autoantibody-positive myasthenia gravis
Shin, Wang, Yim et al
BMC Pharmacol Toxicol (2025) 27 (1), 17 DOI: 10.1186/s40360-025-01056-1
Cited by 1
AI Summary: The NeuroMuscleTM microfluidic device (Ananda Devices Inc.) enabled the creation of a functional human in vitro neuromuscular junction model, while LV-CAG-GCaMP6s lentiviral particles (SignaGen) were used to transduce muscle fibres for calcium imaging, facilitating the study of complement-mediated damage and the protective effect of the C5 inhibitor zilucoplan in myasthenia gravis.
Snippet: o Fisher Scientific) was thawed in a 37 °C water bath and transduced with lentiviral particles at a multiplicity of infection of 20 to express GCaMP6, a fluorescent calcium indicator LV-CAG-GCaMP6s (SignaGen, Frederick, MD, USA). 1.2 × 104 human skeletal myoblasts were injected into the muscle compartment of the NeuroMuscleTM microfluidic device (Ananda Devices Inc.) wi
FigureFigureFigure
Showing 1-1 of 1 papers.
Powered by BizGenius
Shipping Weight 6 lbs
Unit Size

2 x 25 µL at >10⁹ TU/mL, 25 µL at >10⁹ TU/mL

Customers who bought this product also purchased…

Custom Service Solutions


Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.

Important updates waiting for you!

Enter your email address below and subscribe to our newsletter

Enter your email to receive a coupon code for a 15% discount on catalog lentiviruses

This field is required

Unlock a special treat of savings waiting just for you! 🎁

Unlock exclusive deals awaiting you

Your exclusive code is ready! Copy it now!

Get 20% off now for all pre-made LVs